Cryogenic OGS Q4 FY26 Share Price & Earnings Call Analysis

₹374.45+4.99% today
Market cap
₹535 Cr
P/E
47.61
ROE
20.61%
PEG
1.59
Price to sales
10.67
Debt to equity
0.14
52W high / low
₹452 / ₹156
EBITDA margin
29.23%
Net profit margin
21.12%
Promoter holding
74.29%
Sales (last year)
₹50 Cr

Incorporated in 1997, Cryogenic OGS Ltd provides equipment solutions for Metering, Filtering, Pressure Reduction, Dosing, and Blending.[1]

Guidance scorecard · Q4 FY26 call

What Cryogenic OGS's management guided
and where it ranks in Industrial Manufacturing

#32of 54 in
Industrial Manufacturing

RevenueQ3 FY26 call

20–40%
  • Expecting similar growth in the second half of FY26 as in the first half.
  • Order book currently around ₹22-25 crores with ₹65 crores in bids submitted.
  • Facility capacity can support up to double the current revenue without major capex. Significant capex expected only after reaching ₹75-100 crores revenue.
  • Aggressively targeting domestic and global markets, including expansion into LNG and green hydrogen product capabilities.
  • Anticipate repeat and new orders internationally, e.g., large orders in Egypt and Nigeria, and inquiries from Middle East customers.
  • Focus on scaling from domestic engineering base to global integrated solutions platform.

2 more points from Cryogenic OGS's call on revenue

Create a free account to keep reading this call

Full Q3 FY26 analysis

MarginsQ3 FY26 call

Flat

See what Cryogenic OGS said on margins — free account, 30 seconds.

Full Q3 FY26 analysis

CapexQ3 FY26 call

Planned
  • The company is slowly building a new facility, anticipating a need for capex within two years.
  • The new facility development has begun step by step, with early preparations already underway.
  • Current capacity utilization is about 35-40%; significant capex for a new facility is expected after reaching 75 to 100 crores revenue.
  • Past capex done in FY17, FY20, and FY21 improved gross margins; further expansion is planned for 2-3 years down the line.
  • The management expects scope to improve gross margins through higher value addition, new product certifications, and international market expansion.

2 more points from Cryogenic OGS's call on capex

Create a free account to keep reading this call

Full Q3 FY26 analysis

FundraisingQ3 FY26 call

See what Cryogenic OGS said on fundraising — free account, 30 seconds.

Full Q3 FY26 analysis

Order bookQ3 FY26 call

Rising
  • Current order book/post sales: Approximately ₹22 to ₹25 crore.
  • Bids submitted: Around ₹65 crore as of the date.
  • Expectation for the second half of FY26: Similar growth to the first half.
  • Significant ongoing projects: 143 truck loading skids for Egypt and a metering skid project for Honeywell Nigeria.
  • Visibility on future orders: Expecting good orders of similar size in the first half of FY27 and throughout FY27.

2 more points from Cryogenic OGS's call on the order book

Create a free account to keep reading this call

Full Q3 FY26 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Industrial Manufacturing
on management's own guidance

  1. Strong growth
    2
  2. 1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Industrial Manufacturing companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹28,133 Cr75.7
240%+Up 0–2%₹1,185 Cr109.0
340%+Up 0–2%₹486 Cr29.9
440%+Flat₹7,897 Cr92.3
540%+Flat₹3,421 Cr74.4
640%+Flat₹2,461 Cr58.4

Cryogenic OGS announcements

All announcements →

Financials of Cryogenic OGS

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Cryogenic OGS

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Cryogenic OGS

Profit & Loss

Annual income statement trend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2322243341
Expenses +1916182529
Operating Profit466811
OPM %19%26%26%24%28%
Other Income +11113
Interest00000
Depreciation01111
Profit before tax457813
Tax %26%26%25%26%25%
Net Profit +345610
EPS in Rs65.6081.60107.005.837.13
Dividend Payout %0%0%0%0%0%

Financials of Cryogenic OGS

Balance Sheet

Capital structure and asset base

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.500.500.501014
Reserves1317221840
Borrowings +20008
Other Liabilities +76554
Total Liabilities2224283467
Fixed Assets +877716
CWIP00002
Investments11222
Other Assets +1415192547
Total Assets2224283467

Financials of Cryogenic OGS

Cash Flows

Operating, investing and financing cash movement

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +22228
Cash from Investing Activity +-1-0-1-1-21
Cash from Financing Activity +-1-2-0-015
Net Cash Flow10013
Free Cash Flow11226
CFO/OP88%53%52%53%101%

Financials of Cryogenic OGS

Ratios

Working capital efficiency and return ratios

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4185807343
Inventory Days5958106112138
Days Payable1611621165744
Cash Conversion Cycle-60-1971128138
Working Capital Days-5115629591
ROCE %33%34%32%27%
91out of 100

Momentum score · price trend

91 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,920 stocks
Last 12 months+81.6%91%
Last 6 months+92.6%96%
Last 3 months+10.5%81%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,920 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Cryogenic OGS: 0.4 × 91 + 0.4 × 96 + 0.2 × 81 = 91.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 6 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Industrial Manufacturing this season

  • BEW Engg (Q2 FY27)

    6,429.26 Lakhs, approximately 3.64%. Key results statement takeaways from BEW Engineering Ltd's Q2 FY27 results statement — and how it ranks against sector peer

  • Spectrum Electrical Industries (Q2 FY27)

    19,839.33 lakhs in Q2 FY2026, a 68.6% increase. Key results statement takeaways from Spectrum Electrical Industries Ltd's Q2 FY27 results statement — and how it

  • Mamata Machinery (Q2 FY27)

    Q2FY27 Revenue from Operations: ₹4,105 lakh, down 23% YoY from ₹5,337 lakh in Q2FY26 (Page 6). Key investor presentation takeaways from Mamata Machinery Ltd's Q

  • Ishan International (Q2 FY27)

    EBITDA for the quarter: ₹2,566 crore, up 30% year-on-year. Key results statement takeaways from Ishan International Ltd's Q2 FY27 results statement — and how it